某院活血化瘀类中药注射剂使用评价标准建立的探索

doi:10.19803/j.1672-8629.20230140

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (2): 185-189.
DOI: 10.19803/j.1672-8629.20230140

某院活血化瘀类中药注射剂使用评价标准建立的探索

张建¹, 方慧华^2,*

¹江苏省泗洪医院药剂科,江苏宿迁 223900;
²江苏省中医院药学部,江苏南京 210029

收稿日期:2022-08-18 出版日期:2024-02-15 发布日期:2024-02-06
通讯作者: ^*方慧华,男,硕士,副主任中药师,医院药学。E-mail：20210755@njucm.edu.cn
作者简介:张建,女,硕士,主管中药师,临床中药学。
基金资助:
江苏省药学会恒瑞药学基金（H202021）; 江苏省重点研发计划（社会发展）项目（BE2020727）

Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis

ZHANG Jian¹, FANG Huihua^2,*

¹Department of Pharmacy, Sihong Hospital, Suqian Jiangsu 223900, China;
²Department of Pharmacy, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing Jiangsu 210029, China

Received:2022-08-18 Online:2024-02-15 Published:2024-02-06

摘要/Abstract

摘要： 目的建立活血化瘀类中药注射剂临床使用评价标准。方法根据《中华人民共和国药典》（2020年版）、《国家基本医疗保险、工伤保险和生育保险药品目录》（2021年版）、《中成药治疗冠心病临床应用指南》（2020版）、《中成药治疗心力衰竭临床应用指南》（2021年版）梳理所有活血化瘀类中药注射剂,根据其药品说明书信息、指南信息和临床使用情况,设立评价指标,运用德尔菲法建立评价标准。收集2022年1月1日至6月30日某院心内科活血化瘀类中药注射剂使用数据,采用评价标准结合优劣解距离法（technique for order preference by similarity to an ideal solution,TOPSIS）进行评价。结果共纳入21种活血化瘀类中药注射剂适应证,分别从适应证、溶媒、用法用量、辅料和溶剂、配伍使用、特殊人群等方面建立一级、二级评价指标。根据评价结果分析120 例心内科使用活血化瘀类中药注射剂患者中,相对接近度（Ci）≥60% 的有 107例 (89.17%) ,表明某院心内科使用活血化瘀类中药注射剂应用情况基本合理。结论评价标准的建立有利于提高活血化瘀类中药注射剂使用的合理性,可促进活血化瘀类中药注射剂临床的安全使用。

关键词: 心内科, 活血化瘀, 中药注射剂, 药品说明书, 评价标准, 优劣解距离法

Abstract: Objective To establish the standard for evaluation of clinical use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis. Methods According to the National Pharmacopoeia of the People’s Republic of China (2020 edition), the Drug Catalogues for National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (2021), the Guidelines for Clinical Application of Proprietary Chinese Medicine for Coronary Heart Disease (2020 edition) and the Guidelines for Clinical Application of Proprietary Chinese Medicine for Heart Failure (2021), all TCM injections for promoting blood circulation and removing blood stasis were sorted out. According to drug instructions, guidelines and clinical use, the indicators for evaluation were identified, and the standard for evaluation was established using the Delphi method. Data on TCM injections for promoting blood circulation and removing blood stasis used in the Department of Cardiology between January 1 and June 30, 2022 was collected. The Technique for Order Preference by Similarity to an Ideal Solution was used for evaluation. Results A total of 21 indications of TCM injections for promoting blood circulation and removing blood stasis were included before primary and secondary evaluation indexes were established in terms of indications, solvents, usage and dosage, excipients, compatibility and special populations. According to the results of evaluation, 107 patients (89.17%) with Ci≥60% were identified from among 120 patients receiving TCM injections for promoting blood circulation and removing blood stasis, indicating that the usage of these TCM injections in the Department of Cardiology was generally proper. Conclusion The establishment of a standard for evaluation can help improve the rationality of the way in which TCM injections for promoting blood circulation and removing blood stasis are used.

Key words: department of cardiology, promoting blood circulation and removing blood stasis, traditional Chinese medicine injection, drug instructions, standard for valuation, technique for order preference by similarity to an ideal solution

中图分类号:

R944
R994.11

张建, 方慧华. 某院活血化瘀类中药注射剂使用评价标准建立的探索[J]. 中国药物警戒, 2024, 21(2): 185-189.

ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20230140

https://www.zgywjj.com/CN/Y2024/V21/I2/185

参考文献

[1] NMPA. Annual report of national adverse drug reaction monitoring (2021[EB/OLJ]. (2022-03-30)[2022-04-26] . 2021)[EB/OLJ]. (2022-03-30)[2022-04-26] . http://www.nmpa.gov.cn/FGWJ-2021-131.
[2] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,2020 Edition, Volume 1(中华人民共和国药典一部)[M] . Beijing: China Medical Science Press, 2020.
[3] National Healthcare Security Administration, Ministry of Human Resources and Social Security of the People’s Republic of China. On the publication of the drug catalogue of the state basic medical insurance, industrial injury insurance and maternity insurance (2021)(medical insurance issued〔2021〕No. 50)[EB/OL]. (2021-11-24)[2022-03-03].http://www.nhsa.gov.cn/art/2021/12/3/art_37_7429. html.
[4] MAO JY, WU YJ, SHI DZ.Guidelines for clinical application of Chinese patent medicines in the treatment of coronary heart disease (2020)[J]. Chinese Journal of Integrative Medicine on Cardio-cerebrovascular Disease(中西医结合心脑血管病杂志), 2021, 19(9): 1409-1435.
[5] MAO JY, ZHANG J, ZHU MJ.Clinical application guide of Chinese patent medicine in the treatment of heart failure (2021)[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2022, 42(3): 261-275.
[6] WANG HP, CHEN GQ, QIU SS.Establishment and application of drug use evaluation criteria for apixaban[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2022, 31(11): 749-755.
[7] CHEN TD, GAO QL, REN JW, et al.Establishment of index system of accessibility to drugs for chronic diseases based on Delphi method[J]. Chin J Mod Appl Pharm(中国现代应用学),2022, 39(20): 2652-2657.
[8] YU HJ, LIU XM, GU YQ, et al.Construction of nursing quality index system about traditional Chinese medicine in cardiovascular patients based on Delphi method[J]. Journal of Nurses Training(护士进修杂志), 2022, 37(18): 1646-1650.
[9] WU CS, CHEN JX, HU LS.Duble percent method, the new method to determine the weight coefficient in building diagnostic criteria in TCM with Delpi method[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine(中国中医基础医学杂志), 2006(4): 254-255.
[10] YANG WZ, HU ZH, XIE XF, et al.Evaluation on application rationality of antibiotics in patients with acute pancreatitis based on weighted TOPSIS method[J]. Evaluation and Analysis of Drug-use in Hospitals of China(中国医院用药评价与分析), 2021, 21(7): 853-857.
[11] RAN S, YU J, ZHU YL.Application of weighted TOPSIS to evaluate the use of voriconazole in one hospital[J]. Prac J Med＆Pharm(实用医药杂志), 2020, 37(7): 636-641.
[12] WANG GF, LIU RF, LIAO CX, et al.Application of weighted TOPSIS to evaluate the use of voriconazole in one hospital[J]. Evaluation and analysis of drug-use in hospitals of China(中国医院用药评价与分析), 2020, 20(12): 1672-2124.

[1]	李舒冉, 郭姗姗, 高双荣, 包蕾, 耿子涵, 赵荣华, 张敬升, 庞博, 张宇, 王雅欣, 徐英利, 曹姗, 韩冰, 崔晓兰, 孙静. 颅痛宁颗粒对眶下神经缩窄环术诱导三叉神经痛大鼠的治疗作用研究[J]. 中国药物警戒, 2024, 21(3): 257-262.
[2]	熊玮仪, 任经天. 抗肿瘤药说明书安全性信息上市后修订的考虑要点[J]. 中国药物警戒, 2024, 21(1): 94-97.
[3]	刘甜甜, 曹俊岭, 张彦丽, 巩颖, 顾媛媛. 活血化瘀中药增强华法林抗凝作用及机制的研究进展[J]. 中国药物警戒, 2023, 20(1): 117-120.
[4]	钟露苗, 杜娟, 邓华, 王亚锋, 仇萍, 曾令贵. 药品上市许可持有人开展中药注射剂安全性主动监测研究设计和质量管理的思考[J]. 中国药物警戒, 2022, 19(9): 994-998.
[5]	张青霞, 江永贤, 董月鑫, 咸颖, 闫素英. 某三甲医院西药药品说明书贮藏条件风险分析及防范建议[J]. 中国药物警戒, 2022, 19(8): 913-918.
[6]	肖望重, 林聪, 黄莉, 戴冰, 高元峰. 中成药说明书用药禁忌调查分析[J]. 中国药物警戒, 2022, 19(4): 400-403.
[7]	周鹏, 杨晶晶. 3种清热解毒类中药注射剂的药学监护[J]. 中国药物警戒, 2022, 19(4): 441-445.
[8]	易艳, 田婧卓, 李春英, 赵雍, 梁爱华. 中药注射剂上市后非临床安全性再评价类过敏反应相关研究[J]. 中国药物警戒, 2022, 19(2): 185-188.
[9]	赵建彬, 黄玉玲. 基于药品说明书和裁判文书的注射用帕瑞昔布用药风险点探索及应用[J]. 中国药物警戒, 2022, 19(11): 1250-1253.
[10]	张永恒, 韩晨, 杨宵, 韩秀奇, 袁红昌, 邓智建. 313份注射液药品说明书标注信息调查分析[J]. 中国药物警戒, 2021, 18(7): 669-673.
[11]	赵爽, 古瑞, 宋燕青, 王向峰, 苗秋丽. 某院静脉输注抗肿瘤药说明书使用事项标注情况分析[J]. 中国药物警戒, 2021, 18(10): 978-980.
[12]	翁丽洪, 高欢, 胡雪, 张文锐. 39份中药注射液说明书输液信息标注情况分析[J]. 中国药物警戒, 2020, 17(7): 437-440.
[13]	赵爽, 宋燕青, 王相峰, 金芳, 苗秋丽. 抗肿瘤药品说明书中儿童用药信息分析[J]. 中国药物警戒, 2019, 16(9): 555-560.
[14]	胡雪, 张月明, 刘鑫, 张永凯. 75份静脉滴注抗感染药物说明书使用事项标注情况调查与建议[J]. 中国药物警戒, 2019, 16(3): 168-170.
[15]	李岚, 夏东胜, 田春华, 彭丽丽, 高云娟. 甲巯咪唑片安全性风险的分析及思考[J]. 中国药物警戒, 2018, 15(7): 393-397.

某院活血化瘀类中药注射剂使用评价标准建立的探索

Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics